Fujian Cosunter Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 120.05 million compared to CNY 88.23 million a year ago. Net loss was CNY 14.64 million compared to CNY 63.31 million a year ago.

Basic loss per share from continuing operations was CNY 0.0919 compared to CNY 0.3975 a year ago. Diluted loss per share from continuing operations was CNY 0.0919 compared to CNY 0.3975 a year ago.